Overview
A short-acting barbiturate that is effective as a sedative and hypnotic (but not as an anti-anxiety) agent and is usually given orally. It is prescribed more frequently for sleep induction than for sedation but, like similar agents, may lose its effectiveness by the second week of continued administration. (From AMA Drug Evaluations Annual, 1994, p236)
Indication
For the short-term treatment of insomnia.
Associated Conditions
- Convulsions
- Insomnia
Clinical Trials
Title | Posted | Study ID | Phase | Status | Sponsor |
|---|---|---|---|---|---|
2014/09/26 | Phase 1 | Completed | |||
2009/04/08 | Not Applicable | Withdrawn | |||
2008/02/25 | Phase 3 | Terminated | Hospital Universitari Son Dureta | ||
2005/07/25 | Phase 1 | Withdrawn | |||
2003/04/16 | Phase 1 | Completed | Orphan Medical |
FDA Drug Approvals
Approved Product | Manufacturer | NDC Code | Route | Strength | Effective Date |
|---|---|---|---|---|---|
| Sagent Pharmaceuticals | 25021-676 | INTRAVENOUS, INTRAMUSCULAR | 50 mg in 1 mL | 4/18/2017 | |
| Akorn | 17478-181 | INTRAMUSCULAR, INTRAVENOUS | 50 mg in 1 mL | 2/1/2024 | |
| Hikma Pharmaceuticals USA Inc. (dba Leucadia Pharmaceuticals) | 24201-010 | INTRAMUSCULAR, INTRAVENOUS | 50 mg in 1 mL | 1/10/2023 | |
| Akron | 76478-501 | INTRAVENOUS, INTRAMUSCULAR | 50 mg in 1 mL | 2/1/2024 |
EMA Drug Approvals
Approved Product | Authorization Holder | Status | Issued Date |
|---|---|---|---|
| No EMA approvals found for this drug. | |||
HSA Drug Approvals
Approved Product | Manufacturer | Approval Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No HSA approvals found for this drug. | |||||
NMPA Drug Approvals
Approved Product | Company | Approval Number | Drug Type | Dosage Form | Approval Date |
|---|---|---|---|---|---|
| No NMPA approvals found for this drug. | |||||
PPB Drug Approvals
Approved Product | Registration No. | Company | Licence No. | Strength | Registration Date |
|---|---|---|---|---|---|
| No PPB approvals found for this drug. | |||||
TGA Drug Approvals
Approved Product | ARTG ID | Sponsor | Registration Type | Status | Registration Date |
|---|---|---|---|---|---|
| No TGA approvals found for this drug. | |||||
Health Canada Drug Approvals
Approved Product | Company | DIN | Dosage Form | Strength | Market Date |
|---|---|---|---|---|---|
| NEMBUTAL SODIUM INJ 50MG/ML | ABBOTT LABORATORIES, LIMITED | 00000213 | Solution - Intravenous
,
Intramuscular | 50 MG / ML | 12/31/1976 |
| NOVA RECTAL SUP 25MG | sabex inc | 00606502 | Suppository - Rectal | 25 MG / SUP | 12/31/1984 |
| CAFERGOT PB SUP | novartis pharmaceuticals canada inc | 00176214 | Suppository - Rectal | 60 MG / SUP | 12/31/1958 |
| CAFERGOT PB TAB | novartis pharmaceuticals canada inc | 00176222 | Tablet - Oral | 30 MG / TAB | 12/31/1951 |
| NEMBUTAL SODIUM CAP 100MG | ABBOTT LABORATORIES, LIMITED | 00000086 | Capsule - Oral | 100 MG / CAP | 12/31/1951 |
| NOVA RECTAL SUP 50MG | sabex inc | 00606510 | Suppository - Rectal | 50 MG / SUP | 12/31/1984 |
| NOVO-PENTOBARB 100MG | novopharm limited | 00020990 | Capsule - Oral | 100 MG / CAP | 12/31/1967 |
| PENTOBARBITAL SODIUM CAP 50MG | sands pharm | 00233994 | Capsule - Oral | 50 MG / CAP | 12/31/1972 |
CIMA AEMPS Drug Approvals
Approved Product | Company | Registration Number | Pharmaceutical Form | Prescription Type | Status |
|---|---|---|---|---|---|
| No CIMA AEMPS (Spain) approvals found for this drug. | |||||
Philippines FDA Drug Approvals
Approved Product | Company | License Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No Philippines FDA approvals found for this drug. | |||||
Saudi SFDA Drug Approvals
Approved Product | Company | License Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No Saudi SFDA approvals found for this drug. | |||||
Malaysia NPRA Drug Approvals
Approved Product | Company | Registration Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No Malaysia NPRA approvals found for this drug. | |||||
UK EMC Drug Information
Medicine Name | MA Holder | MA Number | Pharmaceutical Form | Active Ingredient | Authorization Date |
|---|---|---|---|---|---|
| No UK EMC drug information found for this drug. | |||||
Help Us Improve
Your feedback helps us provide better drug information and insights.